STORM in the News

LaBiotech: Meet the First Company in the Brand New Field of Epitranscriptomics

Clara Rodríguez Fernández spoke with Keith Blundy, CEO STORM Therapeutics and Hakan Goker, M Ventures about leading the development of the first treatments to target a new layer of genetic information encoded in the RNA.

https://labiotech.eu/interviews/epitranscriptomics-storm-therapeutics/

RNA Epigenetics in Human Disease

A STORM Therapeutics conference | 2021 Dates To be Confirmed

Find out more